Astrazeneca (AZN) Other financing activities (2016 - 2025)
Historic Other financing activities for Astrazeneca (AZN) over the last 14 years, with Q4 2025 value amounting to -$1.0 billion.
- Astrazeneca's Other financing activities fell 6882.26% to -$1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $364.0 million, marking a year-over-year increase of 127419.35%. This contributed to the annual value of $364.0 million for FY2025, which is 127419.35% up from last year.
- According to the latest figures from Q4 2025, Astrazeneca's Other financing activities is -$1.0 billion, which was down 6882.26% from -$352.0 million recorded in Q3 2025.
- Astrazeneca's Other financing activities' 5-year high stood at $1.5 billion during Q2 2024, with a 5-year trough of -$1.9 billion in Q3 2024.
- In the last 5 years, Astrazeneca's Other financing activities had a median value of -$3.5 million in 2021 and averaged $27.8 million.
- As far as peak fluctuations go, Astrazeneca's Other financing activities crashed by 16398248.53% in 2021, and later surged by 610800.0% in 2024.
- Quarter analysis of 5 years shows Astrazeneca's Other financing activities stood at -$15.0 million in 2021, then surged by 200.0% to $15.0 million in 2022, then plummeted by 266.67% to -$25.0 million in 2023, then crashed by 2312.0% to -$603.0 million in 2024, then plummeted by 68.82% to -$1.0 billion in 2025.
- Its Other financing activities stands at -$1.0 billion for Q4 2025, versus -$352.0 million for Q3 2025 and $635.0 million for Q2 2025.